Ultrasound-guided LMBB by Caudal-cranial Approach: Radiographic Comparison of a New Ultrasound-guided Method (BLEPAC)
Chronic Low-back Pain, Lumbar Facet Joint Syndrome
About this trial
This is an interventional treatment trial for Chronic Low-back Pain focused on measuring Pain, fluoroscopy, Ultrasound, Injection Site Infiltration, Chronic, facet infiltration
Eligibility Criteria
Inclusion Criteria: chronic low back pain compatible with facet lumbar syndrome with chronic pain of at least 3 months who have not responded to conservative treatment after at least 4 weeks patients without signs of dissociated pain, radiculitis, neurological diseases including stroke and Parkinson's disease, spinal instability or deformities such as scoliosis, ankylosing spondylitis, history of lumbar surgery, fracture or lumbar tumor Exclusion Criteria: Pregnant or breastfeeding women Allergy to injected products (Depomedrol or Linisol) Psychiatric disorders hindering understanding of the protocol Local or systemic infection Coagulation disorder Obese with a BMI> 35 kg / m²
Sites / Locations
- Hôpital ErasmeRecruiting
Arms of the Study
Arm 1
Experimental
ultrasound guided infiltration verified by fluoroscopy
The 22G needle is introduced along a caudal-cranial axis to infiltrate at each level a volume of 1mL of a mixture consisting of 3mL of Linisol 2% (60mg of lidocaine) and 1mL of Depomedrol (Methylprednisolone) 40mg with 1mL of Omnipaque (contrast product). At each level, contrast medium will be injected at the same time as the linisol-depomedrol mixture so that once the BBM under ultrasound is completed, an X-ray check is performed.